Insulet
PODD
#1126
Rank
S$21.56 B
Marketcap
$307.54
Share price
0.24%
Change (1 day)
31.81%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$2.45 B

According to Insulet's latest financial reports the company's total liabilities are S$2.45 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insulet - Total liabilities on balance sheet (from 2005 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$2.45 B3%
2022-12-31S$2.37 B18.2%
2021-12-31S$2.01 B19.95%
2020-12-31S$1.67 B16.95%
2019-12-31S$1.43 B46.98%
2018-12-31S$0.97 B10.88%
2017-12-31S$0.88 B54.59%
2016-12-31S$0.56 B66.86%
2015-12-31S$0.34 B21.08%
2014-12-31S$0.28 B36.18%
2013-12-31S$0.20 B9.93%
2012-12-31S$0.18 B4.92%
2011-12-31S$0.17 B54.74%
2010-12-31S$0.11 B-30.52%
2009-12-31S$0.16 B44.88%
2008-12-31S$0.11 B107.17%
2007-12-31S$55.61 M-77.17%
2006-12-31S$0.24 B76.57%
2005-12-31S$0.13 B30.65%
2004-12-31S$0.10 B74.29%
2003-12-31S$60.6 M-3.42%
2002-12-31S$62.74 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$2.92 B 19.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.90 B-62.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.68 B 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$142.69 B 5,717.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$43.57 B 1,676.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$54.17 B 2,108.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$75.85 B 2,992.57%๐Ÿ‡บ๐Ÿ‡ธ USA